Hikma Pharmaceuticals Plc Director/PDMR Shareholding (3429E)
February 08 2018 - 6:39AM
UK Regulatory
TIDMHIK
RNS Number : 3429E
Hikma Pharmaceuticals Plc
08 February 2018
Hikma Pharmaceuticals PLC
Notification and public disclosure of transactions by persons
discharging managerial responsibilities
Said Darwazah
1 Details of the person discharging managerial
responsibilities / person closely associated
--- ---------------------------------------------------------------
a) Name Said Darwazah
--- --------------------- ----------------------------------------
2 Reason for the notification
--- ---------------------------------------------------------------
a) Position/status Chairman and Chief Executive Officer
/ PDMR
--- --------------------- ----------------------------------------
b) Initial notification Initial notification
/Amendment
--- --------------------- ----------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- ---------------------------------------------------------------
a) Name Hikma Pharmaceuticals PLC
--- --------------------- ----------------------------------------
b) LEI 549300BNS685UXH4JI75
--- --------------------- ----------------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date;
and (iv) each place where transactions have
been conducted
--- ---------------------------------------------------------------
a) Description Description: Ordinary shares of 10
of the financial pence each
instrument, ID Code: GB00B0LCW083
type of instrument
and identification
code
--- --------------------- ----------------------------------------
b) Nature of Release of a pledge by Darhold Limited
the transaction over 2,000,000 Ordinary Shares of
10 pence each in Hikma Pharmaceuticals
PLC in favour of Europe Arab Bank
Plc. The Chairman and Chief Executive
is a director of and shareholder
in Darhold Limited with an equity
interest of 21.67%.
--- --------------------- ----------------------------------------
c) Price(s) and Price(s): GBP0.00p
volume(s) Volume(s): 2,000,000
--- --------------------- ----------------------------------------
d) Aggregated Aggregated volume: 2,000,000
information Price: GBP0.00p
--- --------------------- ----------------------------------------
e) Date of the 7 December 2017
transaction
--- --------------------- ----------------------------------------
f) Place of the Amman
transaction
--- --------------------- ----------------------------------------
Mazen Darwazah
1 Details of the person discharging managerial
responsibilities / person closely associated
--- ---------------------------------------------------------------
a) Name Mazen Darwazah
--- --------------------- ----------------------------------------
2 Reason for the notification
--- ---------------------------------------------------------------
a) Position/status Executive Vice Chairman / PDMR
--- --------------------- ----------------------------------------
b) Initial notification Initial notification
/Amendment
--- --------------------- ----------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- ---------------------------------------------------------------
a) Name Hikma Pharmaceuticals PLC
--- --------------------- ----------------------------------------
b) LEI 549300BNS685UXH4JI75
--- --------------------- ----------------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date;
and (iv) each place where transactions have
been conducted
--- ---------------------------------------------------------------
a) Description Description: Ordinary shares of 10
of the financial pence each
instrument, ID Code: GB00B0LCW083
type of instrument
and identification
code
--- --------------------- ----------------------------------------
b) Nature of Release of a pledge by Darhold Limited
the transaction over 2,000,000 Ordinary Shares of
10 pence each in Hikma Pharmaceuticals
PLC in favour of Europe Arab Bank
Plc. The Executive Vice Chairman
is a director of and shareholder
in Darhold Limited with an equity
interest of 10.92%.
--- --------------------- ----------------------------------------
c) Price(s) and Price(s): GBP0.00p
volume(s) Volume(s): 2,000,000
--- --------------------- ----------------------------------------
d) Aggregated Aggregated volume: 2,000,000
information Price: GBP0.00p
--- --------------------- ----------------------------------------
e) Date of the 7 December 2017
transaction
--- --------------------- ----------------------------------------
f) Place of the Amman
transaction
--- --------------------- ----------------------------------------
Mohammed 'Ali' Al-Husry
1 Details of the person discharging managerial
responsibilities / person closely associated
--- ----------------------------------------------------------------
a) Name Mohammed 'Ali' Al-Husry
--- --------------------- -----------------------------------------
2 Reason for the notification
--- ----------------------------------------------------------------
a) Position/status Non-Executive Director/ PDMR
--- --------------------- -----------------------------------------
b) Initial notification Initial notification
/Amendment
--- --------------------- -----------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- ----------------------------------------------------------------
a) Name Hikma Pharmaceuticals PLC
--- --------------------- -----------------------------------------
b) LEI 549300BNS685UXH4JI75
--- --------------------- -----------------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date;
and (iv) each place where transactions have
been conducted
--- ----------------------------------------------------------------
a) Description Description: Ordinary shares of 10
of the financial pence each
instrument, ID Code: GB00B0LCW083
type of instrument
and identification
code
--- --------------------- -----------------------------------------
b) Nature of Release of a pledge by Darhold Limited
the transaction over 2,000,000 Ordinary Shares of
10 pence each in Hikma Pharmaceuticals
PLC in favour of Europe Arab Bank
Plc. The Non-Executive Director is
a director of and shareholder in
Darhold Limited with an equity interest
of 8.01%.
--- --------------------- -----------------------------------------
c) Price(s) and Price(s): GBP0.00p
volume(s) Volume(s): 2,000,000
--- --------------------- -----------------------------------------
d) Aggregated Aggregated volume: 2,000,000
information Price: GBP0.00p
--- --------------------- -----------------------------------------
e) Date of the 7 December 2017
transaction
--- --------------------- -----------------------------------------
f) Place of the Amman
transaction
--- --------------------- -----------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBDGDDIXGBGII
(END) Dow Jones Newswires
February 08, 2018 07:39 ET (12:39 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Apr 2024 to May 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From May 2023 to May 2024
